BravoVax Co Ltd

US drug maker Merck & Co., Inc. ( MSD outside North America) is known for its best-selling immuno-oncology agents and vaccines and delivered a high-flying performance in China last year, despite ri

Pfizer Inc. is divesting most rights to its Prevenar 13 vaccine (13-valent, pneumococcal polysaccharide conjugate) in China to a domestic company, in the latest localization move involving vaccines f

From the early rush to get the first made in China COVID-19 vaccine to market, to the country's abrupt policy U-turn on its tough “COVID Zero” restrictions and mass infections at the end of 2022, thre

Another year, another set of pandemic restrictions and disruptions. 2022 was when much of the Chinese healthcare sector, both small and large, domestic and international firms, felt the chill of Beiji